Trastuzumab deruxtecan for HER2-positive metastatic breast cancer: DESTINY-Breast01 subgroup analysis Meeting Abstract
| Authors: | Modi, S.; Andre, F.; Krop, I. E.; Saura, C.; Yamashita, T.; Kim, S. B.; Tamura, K.; Chen, S.; Suto, F.; Kuwahara, Y.; Lee, C. C.; Park, Y. H. |
| Abstract Title: | Trastuzumab deruxtecan for HER2-positive metastatic breast cancer: DESTINY-Breast01 subgroup analysis |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368300206 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.1036 |
| Notes: | Meeting Abstract: 1036 -- Source: Wos |
